Cellular and Gene Therapies Interactive Site Tours Program
Judge refuses to disqualify leading opponents of J&J`s talc bankruptcy plan
July 18 (Reuters) - A close copy version of Abbvie's (ABBV.N), opens new tab blockbuster arthritis drug Humira will be available at a 92% discount to its list price on the GoodRx website, the digital healthcare platform and German drugmaker Boehringer Ingelheim said on Thursday.
After mulling over the data from a failed phase 2 trial, Johnson & Johnson has decided to halt development of its Addex Therapeutics-partnered epilepsy drug, Fierce Biotech has learned. nnThe positive allosteric modulator (PAM) of metabotropic glutamate receptor-2, dubbed ADX71149, emerged from a 2004 collaboration between Addex and J&J’s Janssen unit. Janssen
PRINCETON, NJ / ACCESSWIRE / July 18, 2024 / Bristol Myers Squibb (NYSE:BMY) today announced validation for its near-term and net-zero science-based targets from the Science Based Targets initiative (SBTi), as part of a mid-year update on its environmental initiatives, highlighting progress in reducing emissions across its operations and supply chain. SBTi validation is considered the gold-standard for corporate greenhouse gas (GHG) emissions target setting and reduction strategies.
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (DLA) exercised the first one-year option period of a three-year base contract with two one-year option periods entered into in May 2021. The contract supports DLA's counterfeit mitigation initiatives and product verification and testing programs specific to FSC 5962 microcircuits. The maximal value of the indefinite delivery contract is $1.04 million over an up to five-year performance term. The option-year exercise continues Applied DNA's support of DLA's counterfeit mitigation program, which has been running since 2014.
VANCOUVER, BC / ACCESSWIRE / July 18, 2024 / After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will integrate AI-driven solutions to address the significant challenge of depression among cancer patients, a condition that often complicates treatment and adversely affects overall quality of life.
CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Families across the nation are facing unprecedented delays in neuropsychological assessments for autism, with waitlists extending over a year. North Shore Pediatric Therapy (NSPT) in Chicago is stepping up to meet this critical need. The organization is thrilled to announce that NSPT now offers expedited autism testing for children aged 4 and under, in multiple locations, with appointments available within just three weeks.